The mortality after aneurysmal subarachnoid hemorrhage (SAH) is 50%, and most survivors
suffer severe functional and cognitive deficits. Half of SAH patients deteriorate 5 to 14 days …

Introduction Disabling gait symptoms, especially freezing of gait (FoG), represents a
milestone in the progression of Parkinson's disease (PD). This systematic review and …

Objectives Dorsal root ganglion (DRG) stimulation is a novel treatment of chronic
neuropathic pain and has been shown to be efficacious across several case reports and …

Tumor treating fields (TTFields) is a new modality used for the treatment of glioblastoma. It is
based on antineoplastic low-intensity electric fields induced by two pairs of electrode arrays …

Background Tumor treating fields (TTFields) are increasingly used in the treatment of
glioblastoma. TTFields inhibit cancer growth through induction of alternating electrical fields …

Objective The present work proposes a new clinical approach to TTFields therapy of
glioblastoma. The approach combines targeted surgical skull removal (craniectomy) with …

Background Preclinical studies suggest that skull remodeling surgery (SR-surgery)
increases the dose of tumor treating fields (TTFields) in glioblastoma (GBM) and prevents …

Recording and manipulating neuronal ensemble activity is a key requirement in advanced
neuromodulatory and behavior studies. Devices capable of both recording and manipulating …

Background The high mortality and morbidity after SAH is partly due to DCI, which is
traditionally ascribed to development of angiographic vasospasms. This relation has been …

Objective Spinal cord stimulation (SCS) is an important treatment modality used to treat
chronic neuropathic pain. However, reported success rates of 26%-70% entail an increased …